News and Announcements
Seer Asset Management – Fund Mega Trends
- Published September 06, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Seer are creating an asset management company that will give investors the opportunity to share in owning a funds management business and the opportunity to invest in alternative assets.
- The Company discusses the six underlying Mega Trends that shape the future.
- With a focus on science, technology and innovation (STI) industries.
At Seer the Board and Executive are creating an asset management company that will give investors the opportunity to share in owning a funds management business and the opportunity to invest in alternative assets.
We believe there are six underlying Mega Trends which will critically shape our future.
In particular, within the science, technology and innovation (STI) industries. We will develop funds that will invest in alternative companies embracing the change arising from these Mega Trends.
About Seer Asset Management:
Seer Asset Management will be a diversified funds management group specialising in alternative assets and sustainable investment strategies. We see out investment approach as an opportunity for investors to participate in a multi-thematic strategy, that through positive impact investing will aim to offer risk-adjusted returns to investors focusing on growth opportunities.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
